New clinical study data featuring Nanox.AI's cardiac solution is scheduled to be presented at the Society of Cardiovascular Computed Tomography annual meeting in San Diego, according to reporting by Stock Titan and Yahoo Finance Singapore. The conference, known as SCCT 2026, is one of the major gatherings for specialists in cardiovascular imaging.
Nanox.AI developed an artificial intelligence platform designed to work with cardiac CT imaging. The studies being presented are intended to show how the AI solution performs in clinical settings, though full results were not released ahead of the conference presentations.
The SCCT meeting brings together cardiologists, radiologists, and imaging specialists. Presenting data at the conference is a standard step for medical technology companies seeking peer review and broader clinical adoption of new tools. Nanox.AI's appearance at SCCT 2026 represents the first public clinical data debut for this particular cardiac application.
No pricing, regulatory status, or timeline for broader availability was included in the reports ahead of the San Diego presentations.
